Barun Bhhatarai

Barun Bhhatarai is an accomplished professional with extensive experience in drug metabolism and pharmacokinetics (DMPK), modeling, and toxicology. Currently serving as Associate Director at Frontier Medicines since June 2022, Bhhatarai has previously held positions at Novartis Institutes for BioMedical Research as an Investigator in Modeling & Simulations DMPK and at The Dow Chemical Company as a System Toxicology Informatics Fellow. Bhhatarai's expertise encompasses safety assessment, predictive toxicology, cheminformatics, and regulatory compliance, with significant contributions to major research projects and collaborations with regulatory agencies. Educational qualifications include a PhD and Master's in Physical Chemistry from Clarkson University, as well as a Master's in Organic Chemistry from Tribhuvan University and a Bachelor's in Chemistry.